Announcements
- Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23
- Coloplast A/S - Selskabsmeddelelse nr. 02/2023 - Regnskabsmeddelelse, 1. halvår 2022/23
- Studie viser signifikant forbedring af blæretømning med Coloplasts Luja™ sammenlignet med konkurrentkateter
- Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter
- Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
- Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier
- Coloplast A/S - Allocation of Share Options
- Coloplast A/S - Allokering af aktieoptioner
- Coloplast launches male catheter designed to reduce the risk of urinary tract infections
- Coloplast lancerer nyt kateter til mænd udviklet til at mindske risikoen for urinvejsinfektioner
More ▼
Key statistics
On Friday, Coloplast A/S (CBHD:BRN) closed at 109.67, -1.13% below its 52-week high of 110.92, set on Jul 06, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 109.67 |
---|---|
High | 109.67 |
Low | 109.67 |
Bid | 111.40 |
Offer | 112.02 |
Previous close | 109.67 |
Average volume | -- |
---|---|
Shares outstanding | 198.00m |
Free float | 108.81m |
P/E (TTM) | 39.04 |
Market cap | 174.52bn DKK |
EPS (TTM) | 22.58 DKK |
Annual div (ADY) | 2.62 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | May 15 2023 |
Div pay-date | May 17 2023 |
Data delayed at least 15 minutes, as of Sep 16 2022.
More ▼